Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Daiichi Sankyo
Pharma
FDA signs off on AZ, Daiichi's Datroway for EGFR-mutated NSCLC
AZ and Daiichi have earned their second FDA approval for Datroway, scoring a nod for the drug to treat EGFR-mutated non-small cell lung cancer.
Kevin Dunleavy
Jun 24, 2025 8:10am
Inside ASCO 2025: Big data drops and a towering campaign
Jun 6, 2025 10:39am
PD-1 bispecifics, Enhertu, Regeneron-Hansoh—Fierce Pharma Asia
Jun 6, 2025 7:15am
ASCO: AZ, Daiichi flex Enhertu muscle in 2 cancers
Jun 2, 2025 8:00am
Gilead bolsters Trodelvy with first-line breast cancer win
May 31, 2025 8:00am
Ex-China FDA head, Daiichi, Shanghai Pharma—Fierce Pharma Asia
May 30, 2025 7:00am
